Abstract:Objective To investigate the inhibition of adefovir dipivoxil (ADV ) against duck hepatitis B virus (DHBV ) cccDNA . Methods DHBV naturally infected Peikin ducks fed in Xi′an were used as the animal model and were treated orally with 10 mg · kg -1 of ADV daily for 30 days ,and 0 .5 mL of 0 .01 mol · L -1 PBS was used as the negative control .The levels of DHBV DNA in the peripheral blood were quantified at day 0 ,10 ,20 and 30 of the treatment and at day 15 after the termination of treat‐ment .The serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were examined .Liver tissues of every duck in two groups were obtained by surgery ,and DHBV DNA and cccDNA were determined at day 30 of the treatment and at day 15 after the termination of treatment .Results The serum DHBV DNA levels in ADV treated ducks at day 10 ,20 and 30 of the treatment were significantly reduced as compared with those at baseline of treatment (P< 0 .05) ,and with prolonged treatment ,the serum DHBV DNA levels decreased gradually .At day 15 after the termination of treatment ,the serum DHBV DNA levels were still significantly lower than those at baseline of treatment (P< 0 .05) ,but the rebound of the levels of serum DHBV DNA in ADV treated ducks was observed .At day 20 and 30 of the treatment and day 15 after the termination of treatment ,the se‐rum DHBV DNA levels were significantly lower than those in the negative controls (P< 0 .05) .The levels of liver DHBV DNAin ADV treated ducks at day 30 of the treatment were significantly lower than those in the negative controls and those at baseline of treatment (P< 0 .05) .At day 15 after the termination of treatment ,the levels of liver DHBV DNA were comparable with those in the negative controls and those at baseline of treatment (P> 0 .05) .At day 30 of the treatment and day 15 after the termination of treatment ,the inhibition ratio of cccDNA in ADV treated ducks were significantly reduced as compared with those in negative con‐trols ,suggesting that ADV can effectively inhibit the replication of DHBV cccDNA .No significant change between baseline and end of treatment was observed in ALT and AST in ADV treated ducks .Conclusion ADV can effectively inhibit the replication of DHBV ,particularly ,can make DHBV cccDNA decreased .However ,when the treatment was stopped ,there was a rebound in the levels of DHBV DNA and cccDNA ,indicating that ADV should be combined with other antiviral drugs in clinical treatment and be used long‐termly .

Effects of DNA vaccines coadministered with DuIFN-γ expression plasmid on protection of ducks from DHBV infection

IFN-gamma increases efficiency of DNA vaccine in protecting ducks against infection.

Enhancement of the Immunogenicity of DNA Vaccine Against Infectious Bursal Disease Virus by Co-Delivery with Plasmid Encoding Chicken Interleukin 2.

Immunoenhancement on DNA Vaccine of Polyprotein Gene in Infectious Bursal Disease Virus by Co-Delivery with Plasmid Encoding Chicken Interleukin-18.

Induction of Protective Immune Response in Chickens Immunized with Plasmid DNA Encoding Antigens of Infectious Bursal Disease Virus

Plasmid DNA encoding antigens of infectious bursal disease viruses induce protective immune responses in chickens: factors influencing efficacy.

Immunoenhancement on IBDV DNA vaccine by embryo vaccination with plasmid DNA encoding chicken interleukin-18

[Enhanced Immunogenicity of Plasmid Encoding Polyprotein Gene of Infectious Bursal Disease Virus by Co-Administration of Chicken Interleukin 2 (IL-2)].

The Immunogenicity of CO-expressing Plasmid and Fusion Genes Plasmid Containing IBDV VP2/4/3 and ChIL-18 Genes

Quantitation of IFN-γ Mrna in Duck PBMC and Its Application

Duck CD40L as an adjuvant enhances systemic immune responses of avian flavivirus DNA vaccine

Induction of a Protective Response in Ducks Vaccinated with a DNA Vaccine Encoding Engineered Duck Circovirus Capsid Protein

[Combination of Lamivudine with Thymosin Alpha1 in Treatment of Duck Hepatitis B].

Effect of duck interferon-α and an anti-cap protein polyclonal antibody against duck circovirus

Studies on the inactivation of virus in blood components by using DHBV infected animal model

Synergistic Effects of Adjuvants Interferon-Gamma and Levamisole on Dna Vaccination Against Infection with Newcastle Disease Virus

Recombinant Vaccinia Virus Expressing Pre-S/S Protein of Duck Hepatitis B Virus and Its Preliminary Use for Treatment of Persistent Infection.

Cloning and Expression of Chinese Duck Interferon-Gamma Gene

Oral DNA vaccination with the polyprotein gene of infectious bursal disease virus (IBDV) delivered by attenuated Salmonella elicits protective immune responses in chickens

Research of adefovir dipivoxil against duck hepatitis B virus cccDNA

Establishment of a hydrodynamic delivery system in ducks